| INTRODUC TI ONCardiovascular disease (CVD) is the leading cause of death worldwide, and hypertension is the strongest risk factor for CVD and death. Inadequate blood pressure (BP) control has remained a growing problem despite antihypertensive drugs being one of the most frequently prescribed medications globally. Although meta-analyses and systematic reviews 1,2 indicated that aggressive reduction of BP reduces the risk of CVD, only a small number of randomized controlled trials on treatment targets has been published concerning the extent to which BP should be reduced.
| THE CLINI C AL VALUE OF AOB PThe SPRINT (Systolic Blood Pressure Intervention Trial) addressed this topic and showed that in high-risk patients intensive treatment was more beneficial in reducing cardiovascular risk and death compared to less intensive treatment. 3 Although the findings of SPRINT have been clarified and treatment targets of lower blood pressure levels have been adopted in the Canadian, 4 the Australian 5 and more recently in the 2017 ACC/AHA Hypertension Guidelines, 6 others have been reluctant to follow suit, mainly because of the escalating debate concerning the BP measurement technique in SPRINT. In that study, BP monitors were programed to allow a 5-minute rest before the first BP measurement, take three readings at 1-minute intervals, and display the average. All measurements were obtained using the OMRON HEM-907 XL device, and the method had been known as Automated Office Blood Pressure, or AOBP measurement, during the last decade. As originally described, during the AOBP measurements the patient is alone in the examination room. After the SPRINT trial, this approach has been dubbed "unattended" AOBP measurement by some authors. Although the method for measuring BP in SPRINT was intended to obtain the true baseline BP of the patient, unaffected by external factors such as white coat effect or observer influences, the actual procedures employed in the study were strongly criticized by some seasoned authors in Europe. The criticism on unattended AOBP is focused on two points: first, in a significant number of centers, a nurse remained in the examination room; and second, the original SPRINT publication did not describe in detail the exact procedure followed for the measurement of BP. In point of fact, as presented in an article by Johnson et al in Hypertension, the participants were left alone only during the rest period in 1746 cases, whereas in 570 cases remained alone only during the BP readings. Furthermore, in 2247 cases a healthcare professional remained in the room throughout both the rest period and the entire BP measurement, in contrast to 4082 participants who were always alone. 7This heterogeneity in methodology created concerns regarding the internal validity of the results. It also created new terminology, with AOBP measurements now called "attended" or "unattended." In the SPRINT trial, attended and unattended measurements were taken from different subjects, so the values are not comparable. Still, a subsequ...